India's Glenmark to conduct trials for potential COVID-19 drug, shares jump

Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

from Reuters: Health News https://ift.tt/35fbQ0y